Table 5 Incidence, onset and duration of dizziness with lasmiditan (100 mg and 200 mg doses pooled) by attack
No. of patients (%)a | Onset (median [Q1-Q3]), hrs | Duration (median [Q1-Q3]), hrs | ||||
|---|---|---|---|---|---|---|
Attacks treatedb: | ≥ 1 | All 4 | ≥ 1 | All 4 | ≥ 1 | All 4 |
Attack 1 | 212 (21.8) | 100 (20.2) | 0.7 (0.4-1.2) | 0.7 (0.4-1.3) | 2.5 (1.0-5.8) | 1.8 (1.0-3.9) |
Attack 2 | 124 (15.3) | 71 (14.4) | 0.7 (0.4-1.0) | 0.7 (0.4-1.2) | 3.0 (1.2-6.0) | 2.0 (1.0-4.5) |
Attack 3 | 87 (13.6) | 69 (14.0) | 0.5 (0.4-1.0) | 0.5 (0.4-1.1) | 2.0 (1.0-4.7) | 2.0 (1.0-4.0) |
Attack 4 | 62 (12.6) | 62 (12.6) | 0.7 (0.5-1.0) | 0.7 (0.5-1.0) | 1.8 (1.0-3.2) | 1.8 (1.0-3.2) |